+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Muellerian inhibiting substance blocks autophosphorylation of the egf receptor by inhibiting tyrosine kinase



Muellerian inhibiting substance blocks autophosphorylation of the egf receptor by inhibiting tyrosine kinase



Molecular & Cellular Endocrinology 49(1): 75-86



The fetal regressor Mullerian inhibiting substance (MIS), in concentrations as low as picomolar, inhibited the growth of A-431 cells and the autophosphorylation of its epidermal growth factor (EGF) receptor. The inhibition of membrane phosphorylation was due neither to the reduction of the total number of EGF receptor binding sites, nor to stimulation of intrinsic phosphatases, but rather to inhibition of tyrosine kinase activity. MIS control of EGF receptor autophosphorylation by tyrosine kinase may be one mechanism by which Mullerian duct regression in the embryo and the inhibition of A-431 proliferation is initiated. In addition, MIS as an inhibitor of phosphorylation may furnish a tool to probe the role of membrane phosphorylation in growth control.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005940230

Download citation: RISBibTeXText

PMID: 3030847


Related references

Muellerian inhibiting substance mis blocks autophosphorylation of the egf receptor a possible molecular mechanism of action of mis as an inhibitor of tumor cell growth. Investigational New Drugs: 90, 1987

Muellerian inhibiting substance demonstration of receptor deficiency. Clinical Research 29(1): 109A, 1981

Programmed cell death in the muellerian duct induced by muellerian inhibiting substance. American Journal of Anatomy 149(3): 353-376, 1977

The correlation of glycolization in muellerian inhibiting substance and its activity for muellerian duct regression. Journal Of Cell Biologypart 2: 38a, 1983

Muellerian inhibiting substance receptor characterization with an anti idiotypic antibody. Journal of Urology 139(4 Part 2): 434A, 1988

Insensitivity of the chick embryo muellerian duct to human recombinant muellerian inhibiting substance. Journal of Molecular Endocrinology 8(1): 73-78, 1992

Involution of the muellerian duct under the influence of the muellerian inhibiting substance in an organ culture assay. Anatomical Record 193(3): 657-658, 1979

Antibody against avian muellerian inhibiting substance mis recognizes mis on rat muellerian duct and human tumor cells. Proceedings of the National Science Council Republic of China Part B Life Sciences 13(4): 267-275, 1989

Recombinant human müllerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinase. Growth Factors 1(2): 179-191, 1989

The binding of muellerian inhibiting substance mis and growth hormone gh on chick muellerian duct md corresponds to ductal regression and growth. Journal of Cell Biology 105(4 Part 2): 12A, 1987

Muellerian-inhibiting substance. Gwatkin, R B L Modern Cell Biology; Genes in mammalian reproduction: 185-205, 1993

Control of muellerian inhibiting substance. Kogan, S J And E S E Hafez (Ed ) Clinics in Andrology, Vol 7 Pediatric Andrology; 1st Pan American Congress Of Andrology, Caracas, Venezuela, Feb 1979 Xi+218p Martinus Nijhoff: The Hague, Netherlands; Boston, Mass , Usa Illus P47-52, 1981

The range of activity of muellerian inhibiting substance. Pediatric Research 9(4): 289, 1975

Purification of chick Muellerian-inhibiting substance. Zoological Science 12(Suppl. ): 17, 1995

Muellerian inhibiting substance in reproduction and cancer. Molecular Reproduction & Development 32(2): 168-172, 1992